324 related articles for article (PubMed ID: 29268019)
1. High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target.
VanPatten S; Al-Abed Y
J Med Chem; 2018 Jun; 61(12):5093-5107. PubMed ID: 29268019
[TBL] [Abstract][Full Text] [Related]
2. Stress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming.
Frank MG; Weber MD; Watkins LR; Maier SF
Brain Behav Immun; 2015 Aug; 48():1-7. PubMed ID: 25816800
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.
Andersson U; Yang H; Harris H
Semin Immunol; 2018 Aug; 38():40-48. PubMed ID: 29530410
[TBL] [Abstract][Full Text] [Related]
4. Targeting Inflammation Driven by HMGB1.
Yang H; Wang H; Andersson U
Front Immunol; 2020; 11():484. PubMed ID: 32265930
[TBL] [Abstract][Full Text] [Related]
5. Stress and Alarmins. Report from the 9th iD&EAs meeting.
Mezzapelle R; Venereau E; Bianchi ME
Cell Death Dis; 2019 Dec; 10(12):937. PubMed ID: 31819042
[No Abstract] [Full Text] [Related]
6. Targeting RAGE Signaling in Inflammatory Disease.
Hudson BI; Lippman ME
Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
[TBL] [Abstract][Full Text] [Related]
7. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.
Paudel YN; Angelopoulou E; Piperi C; Balasubramaniam VRMT; Othman I; Shaikh MF
Eur J Pharmacol; 2019 Sep; 858():172487. PubMed ID: 31229535
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 as biomarker and drug target.
Venereau E; De Leo F; Mezzapelle R; Careccia G; Musco G; Bianchi ME
Pharmacol Res; 2016 Sep; 111():534-544. PubMed ID: 27378565
[TBL] [Abstract][Full Text] [Related]
9. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics.
Vijayakumar EC; Bhatt LK; Prabhavalkar KS
Curr Drug Targets; 2019; 20(14):1474-1485. PubMed ID: 31215389
[TBL] [Abstract][Full Text] [Related]
10. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.
Rai V; Agrawal DK
Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820
[TBL] [Abstract][Full Text] [Related]
11. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group box-1 in sterile inflammation.
Tsung A; Tohme S; Billiar TR
J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
[TBL] [Abstract][Full Text] [Related]
13. High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases.
Taverna S; Tonacci A; Ferraro M; Cammarata G; Cuttitta G; Bucchieri S; Pace E; Gangemi S
Cells; 2022 Mar; 11(5):. PubMed ID: 35269471
[TBL] [Abstract][Full Text] [Related]
14. Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review.
De Martinis M; Ginaldi L; Sirufo MM; Pioggia G; Calapai G; Gangemi S; Mannucci C
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32204562
[TBL] [Abstract][Full Text] [Related]
15. The role of high mobility group box 1 in innate immunity.
Lee SA; Kwak MS; Kim S; Shin JS
Yonsei Med J; 2014 Sep; 55(5):1165-76. PubMed ID: 25048472
[TBL] [Abstract][Full Text] [Related]
16. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Andersson U; Ottestad W; Tracey KJ
Mol Med; 2020 May; 26(1):42. PubMed ID: 32380958
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of DAMP signaling as an effective adjunctive treatment strategy in pneumococcal meningitis.
Masouris I; Klein M; Dyckhoff S; Angele B; Pfister HW; Koedel U
J Neuroinflammation; 2017 Nov; 14(1):214. PubMed ID: 29096648
[TBL] [Abstract][Full Text] [Related]
18. [Role of alarmins high mobility group protein B1 in sepsis].
Wei J; Zhang Y; Ma X; Tian L; Liang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):761-4. PubMed ID: 27434574
[TBL] [Abstract][Full Text] [Related]
19. Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1.
Gorgulho CM; Romagnoli GG; Bharthi R; Lotze MT
Front Immunol; 2019; 10():1561. PubMed ID: 31379812
[TBL] [Abstract][Full Text] [Related]
20. HMGB1: endogenous danger signaling.
Klune JR; Dhupar R; Cardinal J; Billiar TR; Tsung A
Mol Med; 2008; 14(7-8):476-84. PubMed ID: 18431461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
